Wealthy executives travel to Mexico for high-cost ibogaine treatments
Wealthy executives, performance biohackers, and public figures are traveling to Cancún, Mexico, to undergo high-cost ibogaine treatments costing up to $20,000, shifting the drug’s demographic footprint away from severe addiction recovery toward lifestyle optimization, nypost.com reported. The psychoactive compound, extracted from African shrub root bark and classified as a Schedule I substance in the United States, is administered to address burnout, existential clarity, and trauma, despite documented cardiac risks.
Ibogaine is a Schedule I controlled substance in the United States with no current approved medical use, but its administration is legally permitted in clinics located in Mexico.
The compound metabolizes in the human body into noribogaine, a secondary metabolite that remains inside the bloodstream for extended periods and may sustain neurological effects.
Clinical screening protocols at facilities like Beōnd Ibogaine require comprehensive medical histories and cardiac evaluations due to documented risks of interfering with the heart’s electrical system.
The Shift From Addiction Recovery to Elite Optimization
While ibogaine has historically drawn clinical interest for addressing substance use disorders and traumatic brain injuries, clinics south of the border are seeing an influx of clients seeking life transformations rather than life-saving interventions. Talia Eisenberg, co-founder of Beōnd Ibogaine in Cancún, noted that the fastest-growing segment consists of health and optimization seekers. High-profile figures, including Marek Health co-founder Mike Stratton, Function Health founder Mark Hyman, Jordan Belfort, and Presley Gerber—the son of Cindy Crawford who received treatment at Beōnd—have turned to the psychoactive compound to rewire their cognitive patterns and confront personal challenges.
For Stratton, who built a career around human optimization, the reality of running a performance-focused company left his own health in disarray. Battling poor eating, constant work demands, and reliance on stimulants, he sought a rapid reset. Stratton described his experience as a grueling psychological journey, noting that unresolved thoughts he was previously unaware of came bursting out simultaneously. Despite the intensity of the multi-day program, which ranges from $12,500 to $20,000 for a 10-day stay, participants report shifts from professional performance pursuits to personal psychological peace.
Noribogaine May Promote Neuroplasticity in the Brain
The physiological impact of ibogaine centers on its conversion into noribogaine, a metabolite that stays active in human circulation far longer than the parent compound. Researchers are actively studying whether this chemical pathway promotes neuroplasticity, defined as the brain’s capacity to modify its structural connections and adapt following profound experiences. Preclinical data from a 2026 animal study demonstrated successful neuroplastic markers in mice, while preliminary human brain-imaging research involving military veterans has indicated measurable alterations in neural activity and network connectivity post-treatment.
Dr. Eduardo Ramirez, clinical director at Beōnd, emphasized that while foundational evidence remains anchored in addiction and trauma populations, active research directions are expanding into healthy cohorts exploring resilience and longevity. Nevertheless, the physiological toll of the compound requires strict clinical oversight. Ramirez warned that ibogaine must not be treated as a recreational psychedelic. Because the substance directly interferes with the heart’s electrical system and can trigger dangerous abnormal rhythms, receiving facilities routinely enforce rigorous pre-arrival health reviews and specialized cardiac testing.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.